PATENT CLAIM ANALYSIS

Application Number: 15763050
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-09
Patent Classification: ["514", "011700"]

Abstract:
Certain embodiments are directed to a formulation of a therapeutic agent, as well as a method of making such a formulation, comprising at least one therapeutic agent dissolved in an aprotic polar solvent system comprising at least one ionization stabilizing excipient in a concentration sufficient to impart physical and chemical stability to the therapeutic agent.

Claim (Index 1):
A stable formulation comprising:\n (a) a glucagon peptide or salt thereof; (b) an ionization stabilizing excipient; and (c) an aprotic polar solvent; wherein (i) the glucagon peptide or salt thereof is dissolved in the aprotic solvent in an amount from about 0.1 mg/mL up to the solubility limit of the glucagon peptide or salt thereof, and (ii) the ionization stabilizing excipient is dissolved in the aprotic solvent in an amount to stabilize the ionization of the glucagon peptide or salt thereof.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 90.0
- Lexical Diversity: 1.48718
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15136650', '15594998', '14192679', '14188464', '13417073']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7775534293181009
- 35 USC 102 Novelty (BERT): 0.5552642592466848
- Combined Prediction Score: 0.7553245123109593
- Mean Citation Score: 344.632076
- Max Citation Score: 421.67606
- Similarity Product: 385.5156858571912

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test